These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

230 related items for PubMed ID: 17378256

  • 61. [Anaphylaxis and biphasic reaction in a children hospital].
    Nagano C, Ishiguro A, Yotani N, Sakai H, Fujiwara T, Ohya Y.
    Arerugi; 2013 Feb; 62(2):163-70. PubMed ID: 23531652
    [Abstract] [Full Text] [Related]

  • 62. Diagnostic role of serum tryptase in anaphylactic deaths in forensic medicine: a systematic review and meta-analysis.
    Sun KJ, He JT, Huang HY, Xue Y, Xie XL, Wang Q.
    Forensic Sci Med Pathol; 2018 Jun; 14(2):209-215. PubMed ID: 29679215
    [Abstract] [Full Text] [Related]

  • 63. Mast cell tryptase in postmortem serum-reference values and confounders.
    Edston E, Eriksson O, van Hage M.
    Int J Legal Med; 2007 Jul; 121(4):275-80. PubMed ID: 16710735
    [Abstract] [Full Text] [Related]

  • 64.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 65. Fatal and near-fatal anaphylaxis: factors that can worsen or contribute to fatal outcomes.
    Greenberger PA.
    Immunol Allergy Clin North Am; 2015 May; 35(2):375-86. PubMed ID: 25841558
    [Abstract] [Full Text] [Related]

  • 66.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 67.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 68. Anaphylaxis: mechanisms and management.
    Lee JK, Vadas P.
    Clin Exp Allergy; 2011 Jul; 41(7):923-38. PubMed ID: 21668816
    [Abstract] [Full Text] [Related]

  • 69.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 70.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 71. Fatal Anaphylaxis: Epidemiology and Risk Factors.
    Mikhail I, Stukus DR, Prince BT.
    Curr Allergy Asthma Rep; 2021 Apr 07; 21(4):28. PubMed ID: 33825067
    [Abstract] [Full Text] [Related]

  • 72.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 73. Epidemiology of drug-induced anaphylaxis in a tertiary hospital in Korea.
    Park HK, Kang MG, Yang MS, Jung JW, Cho SH, Kang HR.
    Allergol Int; 2017 Oct 07; 66(4):557-562. PubMed ID: 28291680
    [Abstract] [Full Text] [Related]

  • 74.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 75. Epidemiology of Anaphylaxis: Contributions From the Last 10 Years.
    Tejedor-Alonso M A, Moro-Moro M, Múgica-García MV.
    J Investig Allergol Clin Immunol; 2015 Oct 07; 25(3):163-75; quiz follow 174-5. PubMed ID: 26182682
    [Abstract] [Full Text] [Related]

  • 76. Reproducibility of Symptom Sequences Across Episodes of Recurrent Anaphylaxis.
    Slapnicar C, Lebovic G, McParland A, Dozois M, Vadas P.
    J Allergy Clin Immunol Pract; 2022 Feb 07; 10(2):534-538.e1. PubMed ID: 34933152
    [Abstract] [Full Text] [Related]

  • 77. Vaccination and anaphylaxis: a forensic perspective.
    Palmiere C, Tettamanti C, Scarpelli MP.
    Croat Med J; 2017 Feb 28; 58(1):14-25. PubMed ID: 28252871
    [Abstract] [Full Text] [Related]

  • 78.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 79. Increases in anaphylaxis fatalities in Australia from 1997 to 2013.
    Mullins RJ, Wainstein BK, Barnes EH, Liew WK, Campbell DE.
    Clin Exp Allergy; 2016 Aug 28; 46(8):1099-110. PubMed ID: 27144664
    [Abstract] [Full Text] [Related]

  • 80. Clinical and demographic characteristics of fatal anaphylaxis in Spain (1998-2011): A comparison between a series from the hospital system and a national forensic series.
    Tejedor-Alonso MA, Martínez-Fernandez P, Vallejo-de-Torres G, Navarro-Escayola E, Moro-Moro M, Alberti-Masgrau N.
    Clin Exp Allergy; 2019 Jan 28; 49(1):82-91. PubMed ID: 30204277
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.